{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:30:30Z","timestamp":1759937430474,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.canlet.2008.04.002","type":"journal-article","created":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T05:03:00Z","timestamp":1211259780000},"page":"278-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["siRNA-mediated Erc gene silencing suppresses tumor growth in Tsc2 mutant renal carcinoma model"],"prefix":"10.1016","volume":"268","author":[{"given":"Osamu","family":"Imamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okio","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2008.04.002_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF01197777","article-title":"Renal carcinogenesis in the Eker rat","volume":"121","author":"Hino","year":"1995","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.04.002_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1349-7006.2007.00520.x","article-title":"Diagnostic biomarker of asbestos-related mesothelioma: example of translational research","volume":"98","author":"Hino","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2008.04.002_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1349-7006.2007.00438.x","article-title":"Establishment of the enzyme-linked immunosorbent assay system to detect the amino terminal secretory form rat Erc\/mesothelin","volume":"98","author":"Nakaishi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2008.04.002_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1349-7006.2006.00246.x","article-title":"Novel ELISA system for detection of N-ERC\/mesothelin in the sera of mesothelioma patients","volume":"97","author":"Shiomi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2008.04.002_bib5","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1078-0432.CCR-07-1613","article-title":"Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC\/mesothelin increases its potential as a useful serum tumor marker for mesothelioma","volume":"14","author":"Shiomi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.002_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000100446","article-title":"Blood tests for asbestos-related mesothelioma","volume":"71","author":"Maeda","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2008.04.002_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy","volume":"44","author":"Hassan","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2008.04.002_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0076-6879(04)92016-2","article-title":"RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics","volume":"392","author":"De Fougerolles","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.canlet.2008.04.002_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jgm.659","article-title":"Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels","volume":"7","author":"Hassani","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.canlet.2008.04.002_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.gt.3302425","article-title":"RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo","volume":"12","author":"Urban-Klein","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.002_bib11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0006-291X(02)00736-2","article-title":"Gene silencing in mammalian cells by preformed small RNA duplexes","volume":"295","author":"Leirdal","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2008.04.002_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic siRNAs in adult mice","volume":"327","author":"Sorensen","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.canlet.2008.04.002_bib13","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.4049\/jimmunol.170.7.3653","article-title":"SS-A\/Ro52, an autoantigen involved in CD28-mediated IL-2 production","volume":"170","author":"Ishii","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2008.04.002_bib14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/jgm.753","article-title":"Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin","volume":"7","author":"Ito","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.canlet.2008.04.002_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ymthe.2006.03.022","article-title":"Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma","volume":"14","author":"Kim","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2008.04.002_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2006.01.022","article-title":"siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene","volume":"112","author":"Zhang","year":"2006","journal-title":"J. Control Release"},{"key":"10.1016\/j.canlet.2008.04.002_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2006.05.023","article-title":"PEG conjugated VEGF siRNA for anti-angiogenic gene therapy","volume":"116","author":"Kim","year":"2006","journal-title":"J. Control Release"},{"key":"10.1016\/j.canlet.2008.04.002_bib18","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1007\/s11095-006-9009-2","article-title":"Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro","volume":"23","author":"Grayson","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.canlet.2008.04.002_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2006.02.009","article-title":"A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes","volume":"112","author":"Werth","year":"2006","journal-title":"J. Control Release"},{"key":"10.1016\/j.canlet.2008.04.002_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1349-7006.2006.00174.x","article-title":"Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma","volume":"97","author":"Matsumoto","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2008.04.002_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2007.11.017","article-title":"Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice","volume":"126","author":"Murata","year":"2008","journal-title":"J. Control Release"},{"key":"10.1016\/j.canlet.2008.04.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v12.i1.10","article-title":"Biodegradable microspheres in drug delivery","volume":"12","author":"Okada","year":"1995","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.canlet.2008.04.002_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1158\/1541-7786.MCR-07-0254","article-title":"Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells","volume":"6","author":"Uehara","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.002_bib24","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1158\/0008-5472.CAN-05-3582","article-title":"HSulf-1 inhibits angiogenesis and tumorigenesis in vivo","volume":"66","author":"Narita","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.002_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1173","article-title":"Induction of an interferon response by RNAi vectors in mammalian cells","volume":"34","author":"Bridge","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2008.04.002_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"25","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.04.002_bib27","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to Mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2008.04.002_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, meotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2008.04.002_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2008.04.002_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0046-8177(03)00177-1","article-title":"Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas","volume":"34","author":"Frierson","year":"2003","journal-title":"Hum. Pathol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508002772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508002772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:28:07Z","timestamp":1759591687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383508002772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0304383508002772"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2008.04.002","relation":{},"ISSN":["0304-3835"],"issn-type":[{"type":"print","value":"0304-3835"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"siRNA-mediated Erc gene silencing suppresses tumor growth in Tsc2 mutant renal carcinoma model","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2008.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}